Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors

Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors

Abstract. Background:. Lung cancer is the second most common cancer worldwide, with non-small-cell lung cancer (NSCLC) accounting for the majority of cases. Patients with NSCLC have achieved great survival benefits from immunotherapies targeting immune checkpoints. Glucocorticoids (GCs) are frequent...

Full description

Bibliographic Details
Main Authors: Nijiao Li, Xuliang Zheng, Jinyan Gan, Ting Zhuo, Xiaohong Li, Chuyi Yang, Yanbin Wu, Shouming Qin, Xiangxiang Pan, Peifang Wei
Format: Article
Language:English
Published: Wolters Kluwer 2023-11-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000002544

Internet

http://journals.lww.com/10.1097/CM9.0000000000002544

Similar Items